These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15906378)

  • 21. Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1.
    Baek KH; Zaslavsky A; Lynch RC; Britt C; Okada Y; Siarey RJ; Lensch MW; Park IH; Yoon SS; Minami T; Korenberg JR; Folkman J; Daley GQ; Aird WC; Galdzicki Z; Ryeom S
    Nature; 2009 Jun; 459(7250):1126-30. PubMed ID: 19458618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome.
    Billingsley CN; Allen JR; Baumann DD; Deitz SL; Blazek JD; Newbauer A; Darrah A; Long BC; Young B; Clement M; Doerge RW; Roper RJ
    Am J Med Genet A; 2013 Aug; 161A(8):1866-74. PubMed ID: 23843306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.
    Liu W; Zhou H; Liu L; Zhao C; Deng Y; Chen L; Wu L; Mandrycky N; McNabb CT; Peng Y; Fuchs PN; Lu J; Sheen V; Qiu M; Mao M; Lu QR
    Neurobiol Dis; 2015 May; 77():106-16. PubMed ID: 25747816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene.
    Fuentes JJ; Pritchard MA; Estivill X
    Genomics; 1997 Sep; 44(3):358-61. PubMed ID: 9325060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chromosome 21 critical region does not cause specific Down syndrome phenotypes.
    Olson LE; Richtsmeier JT; Leszl J; Reeves RH
    Science; 2004 Oct; 306(5696):687-90. PubMed ID: 15499018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down syndrome mouse models are looking up.
    Reeves RH
    Trends Mol Med; 2006 Jun; 12(6):237-40. PubMed ID: 16677859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in mice.
    Liu C; Morishima M; Jiang X; Yu T; Meng K; Ray D; Pao A; Ye P; Parmacek MS; Yu YE
    Hum Genet; 2014 Jun; 133(6):743-53. PubMed ID: 24362460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct biomechanical induction of endogenous calcineurin inhibitor Down Syndrome Critical Region-1 in cardiac myocytes.
    Wang Y; De Keulenaer GW; Weinberg EO; Muangman S; Gualberto A; Landschulz KT; Turi TG; Thompson JF; Lee RT
    Am J Physiol Heart Circ Physiol; 2002 Aug; 283(2):H533-9. PubMed ID: 12124198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DSCR1-mediated TET1 splicing regulates miR-124 expression to control adult hippocampal neurogenesis.
    Choi C; Kim T; Chang KT; Min KT
    EMBO J; 2019 Jul; 38(14):e101293. PubMed ID: 31304631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The calcineurin-NFAT pathway negatively regulates megakaryopoiesis.
    Zaslavsky A; Chou ST; Schadler K; Lieberman A; Pimkin M; Kim YJ; Baek KH; Aird WC; Weiss MJ; Ryeom S
    Blood; 2013 Apr; 121(16):3205-15. PubMed ID: 23446734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells.
    Lee MY; Garvey SM; Baras AS; Lemmon JA; Gomez MF; Schoppee Bortz PD; Daum G; LeBoeuf RC; Wamhoff BR
    Hum Mol Genet; 2010 Feb; 19(3):468-79. PubMed ID: 19926569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Down Syndrome Critical Region 1 expression by Nuclear Factor of Activated T cells in megakaryocytes.
    Kyttälä S; Habermann I; Minami T; Ehninger G; Kiani A
    Br J Haematol; 2009 Feb; 144(3):395-408. PubMed ID: 19036088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dscr1, a novel endogenous inhibitor of calcineurin signaling, is expressed in the primitive ventricle of the heart and during neurogenesis.
    Casas C; Martínez S; Pritchard MA; Fuentes JJ; Nadal M; Guimerà J; Arbonés M; Flórez J; Soriano E; Estivill X; Alcántara S
    Mech Dev; 2001 Mar; 101(1-2):289-92. PubMed ID: 11231093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
    Liu X; Zhao D; Qin L; Li J; Zeng H
    J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single extra copy of Down syndrome critical region 1-4 results in impaired hepatic glucose homeostasis.
    Seo DS; Chau GC; Baek KH; Um SH
    Mol Metab; 2019 Mar; 21():82-89. PubMed ID: 30583978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo.
    Chan B; Greenan G; McKeon F; Ellenberger T
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13075-80. PubMed ID: 16131541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased dosage of DYRK1A and DSCR1 delays neuronal differentiation in neocortical progenitor cells.
    Kurabayashi N; Sanada K
    Genes Dev; 2013 Dec; 27(24):2708-21. PubMed ID: 24352425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trisomy 1q43 syndrome: a consistent phenotype with macrocephaly, characteristic face, developmental delay and cardiac anomalies.
    Morava E; Jackson KE; Tsien F; Marble MR
    Genet Couns; 2004; 15(4):449-53. PubMed ID: 15658621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conotruncal anomalies in the trisomy 16 mouse: an immunohistochemical analysis with emphasis on the involvement of the neural crest.
    Waller BR; McQuinn T; Phelps AL; Markwald RR; Lo CW; Thompson RP; Wessels A
    Anat Rec; 2000 Nov; 260(3):279-93. PubMed ID: 11066038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new gene family including DSCR1 (Down Syndrome Candidate Region 1) and ZAKI-4: characterization from yeast to human and identification of DSCR1-like 2, a novel human member (DSCR1L2).
    Strippoli P; Lenzi L; Petrini M; Carinci P; Zannotti M
    Genomics; 2000 Mar; 64(3):252-63. PubMed ID: 10756093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.